Cargando…
A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer
Ribonucleotide reductase (RR) is a unique enzyme for the reduction of NDPs to dNDPs, the building blocks for DNA synthesis and thus essential for cell proliferation. Pan-cancer profiling studies showed that RRM2, the small subunit M2 of RR, is abnormally overexpressed in multiple types of cancers; h...
Autores principales: | Liu, Qian, Guo, Lijuan, Qi, Hongyan, Lou, Meng, Wang, Rui, Hai, Boning, Xu, Kailun, Zhu, Lijun, Ding, Yongfeng, Li, Chen, Xie, Lingdan, Shen, Jing, Xiang, Xueping, Shao, Jimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263627/ https://www.ncbi.nlm.nih.gov/pubmed/34234118 http://dx.doi.org/10.1038/s41419-021-03969-1 |
Ejemplares similares
-
Knockdown MTDH Inhibits Glioma Proliferation and Migration and Promotes Apoptosis by Downregulating MYBL2
por: Fu, Junqi, et al.
Publicado: (2022) -
MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia
por: Clarke, M, et al.
Publicado: (2013) -
Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients
por: Jia, Yongxu, et al.
Publicado: (2019) -
MYBL2 and ATM suppress replication stress in pluripotent stem cells
por: Blakemore, Daniel, et al.
Publicado: (2021) -
Increased
MYBL2
expression in aggressive hormone‐sensitive prostate cancer
por: Yoshikawa, Yuki, et al.
Publicado: (2022)